1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（微信公众号信息）：

https://www.keaipublishing.com/en/journals/dental-research/

https://www.sciencedirect.com/journal/dental-research

4、投稿系统：

https://www.editorialmanager.com/dtrs

5、官网电话：020-37574597

6、官网邮箱：dentalresearch@mail.sysu.edu.cn

7、出刊日期：季刊，一年出版四期。

8、官方微信公众号：Dental Research

9、官网信息：2026年12月31日前投稿不收APC

2026年1月19日星期一

Guide for authors

【官网信息】

About the journal

Journal announcements

Dental

Research (DR) is an international, peer-reviewed, open-access journal,

managed and owned by Hospital of Stomatology, Sun Yat-sen University.

Dental Research aims to become a world-class English-language scientific

journal, publishing original researches and review articles on a

quarterly basis. While focusing on the latest advances in dentistry,

oral and craniofacial sciences, the journal also covers cutting-edge

developments in regenerative medicine, biomaterials, life sciences,

biotechnology, and systemic diseases to foster interdisciplinary

innovation.

Aims and scope

Dental

Research is an international peer-reviewed scientific journal dedicated

to dental, oral, and craniofacial sciences. It publishes innovative

research spanning basic, clinical and translational studies, including

interdisciplinary work that integrates these fields with basic medicine,

clinical medicine, preventive medicine, life sciences, biomedical

engineering, materials science and engineering.

Covered

Areas Include: Stem Cells & Regenerative Medicine, Craniofacial

Growth and Development, Bone/Cartilage Development & Pathogenesis,

Bone Metabolism & Regenerative Repair, Biomaterials,

Biopharmaceuticals, Artificial intelligence & Computational Biology,

Oncology, Microbiology, Inflammation & Immunomodulation,

Epidemiology and Oral-systemic Disease Interactions.

Editorial Board

Article types

Dental

Research publishes the following article types (word counts exclude

abstract, references, tables and figures unless noted):

Article type

Requirements

Original Research

≤ 6,000 words; unstructured abstract ≤

300 words; minimum 6 original figures, with a resolution of no less

than 300 dpi; tables submitted as one editable word document with

unlimited quantity; references minimum 40 citations. Supplementary

figures and their legends, tables, and additional materials should be

combined into one single Word document (.docx). Multimedia files, such

as videos, should be submitted as separate files. Keywords: up to 5

terms.

Review Article

≤ 8,000 words; unstructured abstract ≤

300 words; minimum 3 original figures, with a resolution of no less

than 300 dpi; tables submitted as one editable word document with

unlimited quantity; references minimum 80 citations. Supplementary

figures and their legends, tables, and additional materials should be

combined into one single Word document (.docx). Multimedia files, such

as videos, should be submitted as separate files. Keywords: up to 5

terms.

Peer review

This

journal follows a single anonymized review process. Your submission

will initially be assessed by our editors to determine suitability for

publication in this journal. If your submission is deemed suitable, it

will typically be sent to a minimum of two reviewers for an independent

expert assessment of the scientific quality. The decision as to whether

your article is accepted or rejected will be taken by our editors. This

decision is final.

Our editors are not involved in making decisions about papers which:

they have written themselves.

have been written by family members or colleagues.

relate to products or services in which they have an interest.

Any

such submissions will be subject to the journal's usual procedures and

peer review will be handled independently of the editor involved and

their research group.

All

manuscripts are reviewed by the editorial office. Any papers which fail

to meet the basic standards of the journal will be desk-rejected for

reasons like out of scope, ethical conflicts, high similarities, lack of

originality, flaws in research design or methods, etc. The editorial

office will reassign selected papers to the Editor-in-chief.

The

Editor-in-chief will invite multiple reviewers to review the paper or

assign an editorial board member to invite reviewers to review this

paper.

After

at least two reviewers give their reviews and comments, the

Editor-in-chief (or the assigned Editor) provides feedback to the

authors, based on reviewer comments and his own review comments.

When

the author submits the revised manuscript, the assigned editor and

Editor-in-chief will collaborate to make a final decision.

For

submissions from the Editor-in-Chief, Associate Editors, Guest

Editor(s), other journal Board members, and authors who have conflicts

of interest with them, we ensure that the paper is handled

confidentially by a different team member.

For

submissions to Special Issues; if there are conflicts of interest

between the Guest Editor(s) and authors, the submissions will be handled

by another Editor from the Editorial Board who will manage the peer

review process and make the decision whether to accept or reject the

paper after peer review.

Read more about peer review.

KeAi Guide for authors: Open Access

This

is an open access journal: all articles will be immediately and

permanently free for everyone to read and download. To provide open

access, this journal has an open access fee (also known as an article

publishing charge APC) which needs to be paid by the authors or on their

behalf e.g. by their research funder or institution.

Creative Commons Attribution (CC BY)

Allows

users to: distribute and copy the article; create extracts, abstracts,

and other revised versions, adaptations or derivative works of or from

an article (such as a translation); include in a collective work (such

as an anthology); and text or data mine the article. These uses are

permitted even for commercial purposes, provided the user: gives

appropriate credit to the author(s) (with a link to the formal

publication through the relevant DOI); includes a link to the license;

indicates if changes were made; and does not represent the author(s) as

endorsing the adaptation of the article or modify the article in such a

way as to damage the authors' honor or reputation.

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Allows

users to: distribute and copy the article; and include in a collective

work (such as an anthology). These uses are permitted only for

non-commercial purposes, and provided the user: gives appropriate credit

to the author(s) (with a link to the formal publication through the

relevant DOI); provides a link to the license; and does not alter or

modify the article.

If

you need to comply with your funding body policy you can apply for a CC

BY license after your manuscript is accepted for publication.

Article Publishing Charge (APC)

As

an open access journal with no subscription charges, a fee (Article

Publishing Charge, APC) is payable by the authors, or their institution

or funders, to cover the costs associated with publication. This ensures

your article will be immediately and permanently free to access by

everyone.

All APCs for articles submitted to the journal before 31-12-2026 will be fully waived.

Ethics and policies

Ethics in publishing

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Submission declaration

When authors submit an article to a journal it is implied that:

the

work described has not been published previously except in the form of a

preprint, an abstract, a published lecture or academic thesis. See our

policy on multiple, redundant or concurrent publication.

the article is not under consideration for publication elsewhere.

the

article’s publication is approved by all authors and tacitly or

explicitly by the responsible authorities where the work was carried

out.

if

accepted, the article will not be published elsewhere in the same form,

in English or in any other language, including electronically without

the written consent of the copyright-holder.

Submissions

to KeAi journals are automatically screened using iThenticate's

CrossCheck within the editorial system to detect plagiarism issues

including instances of overlapping and similar text in submitted

manuscripts. Details can be found here. High similarity papers will be

desk rejected.

ORCiD ID: Our journal supports the use of ORCiD ID. Authors are encouraged to provide ORCiD ID at submission.

Authorship

All authors should have made substantial contributions to all of the following:

The conception and design of the study, or acquisition of data, or analysis and interpretation of data.

Drafting the article or revising it critically for important intellectual content.

Final approval of the version to be submitted.

Authors

should appoint a corresponding author to communicate with the journal

during the editorial process. All authors should agree to be accountable

for all aspects of the work to ensure that the questions related to the

accuracy or integrity of any part of the work are appropriately

investigated and resolved.

Changes to authorship

The

editors of this journal generally will not consider changes to

authorship once a manuscript has been submitted. It is important that

authors carefully consider the authorship list and order of authors and

provide a definitive author list at original submission.

The policy of this journal around authorship changes:

All authors must be listed in the manuscript and their details entered into the submission system.

Any

addition, deletion or rearrangement of author names in the authorship

list should only be made prior to acceptance, and only if approved by

the journal editor.

Requests

to change authorship should be made by the corresponding author, who

must provide the reason for the request to the journal editor with

written confirmation from all authors, including any authors being added

or removed, that they agree with the addition, removal or

rearrangement.

All

requests to change authorship must be submitted using this form.

Requests which do not comply with the instructions outlined in the form

will not be considered.

Only

in exceptional circumstances will the journal editor consider the

addition, deletion or rearrangement of authors post acceptance.

Publication of the manuscript may be paused while a change in authorship request is being considered.

Any

authorship change requests approved by the journal editor will result

in a corrigendum if the manuscript has already been published.

Any

unauthorized authorship changes may result in the rejection of the

article, or retraction, if the article has already been published.

Declaration of competing interests

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence or

bias their work. Examples of potential competing interests include:

Employment

Consultancies

Stock ownership

Honoraria

Paid expert testimony

Patent applications or registrations

Grants or any other funding

Affiliation with the journal as an Editor or Advisory Board Member

The declarations tool should always be completed.

Authors

with a journal affiliation to declare should enter the following text

under “Other Activities” within the declarations tool and should inform

the journal and publisher prior to completing the submission process:

Given their role as [insert journal role title], [insert your name] had

no involvement in the peer-review of this article and has no access to

information regarding its peer-review. Full responsibility for the

editorial process for this article was delegated to another journal

editor.

Authors with no competing interests to declare should select the option "I have nothing to declare".

The

resulting Word document containing your declaration should be uploaded

at the "attach/upload files" step in the submission process. It is

important that the Word document is saved in the .doc/.docx file format.

Author signatures are not required.

Funding sources

Authors

must disclose any funding sources who provided financial support for

the conduct of the research and/or preparation of the article. The role

of sponsors, if any, should be declared in relation to the study design,

collection, analysis and interpretation of data, writing of the report

and decision to submit the article for publication. If funding sources

had no such involvement this should be stated in your submission.

List funding sources in this standard way to facilitate compliance to funder's requirements:

Funding:

This work was supported by the National Institutes of Health [grant

numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle,

WA [grant number zzzz]; and the United States Institutes of Peace [grant

number aaaa].

It

is not necessary to include detailed descriptions on the program or

type of grants, scholarships and awards. When funding is from a block

grant or other resources available to a university, college, or other

research institution, submit the name of the institute or organization

that provided the funding.

If no funding has been provided for the research, it is recommended to include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Declaration of generative AI in scientific writing

Authors

are encouraged to declare the use of generative AI in scientific

writing upon submission of the paper. The following guidance refers only

to the writing process, and not to the use of AI tools to analyse and

draw insights from data as part of the research process:

Generative

AI and AI-assisted technologies should only be used in the writing

process to improve the readability and language of the manuscript.

The

technology must be applied with human oversight and control and authors

should carefully review and edit the result, as AI can generate

authoritative-sounding output that can be incorrect, incomplete or

biased. Authors are ultimately responsible and accountable for the

contents of the work.

Authors

must not list or cite AI and AI-assisted technologies as an author or

co-author on the manuscript since authorship implies responsibilities

and tasks that can only be attributed to and performed by humans.

The

use of generative AI and AI-assisted technologies in scientific writing

can be declared by adding a statement at the end of the manuscript when

the paper is first submitted. The statement will appear in the

published work and should be placed in a new section before the

references list. An example:

Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.

Statement:

During the preparation of this work the author(s) used [NAME TOOL /

SERVICE] in order to [REASON]. After using this tool/service, the

author(s) reviewed and edited the content as needed and take(s) full

responsibility for the content of the published article.

The

declaration does not apply to the use of basic tools, such as tools

used to check grammar, spelling and references. If you have nothing to

disclose, you do not need to add a statement.

We advise you to read our policy for authors on the use of generative AI and AI-assisted technologies for Elsevier.

Please

note: to protect authors’ rights and the confidentiality of their

research, this journal does not currently allow the use of Generative AI

or AI-assisted technologies such as ChatGPT or similar services by

reviewers or editors in the peer review and manuscript evaluation

process. We are actively evaluating compliant AI tools and may revise

this policy in the future.

Preprint sharing

Authors

may share preprints in line with Elsevier's article sharing policy.

Sharing preprints, such as on a preprint server, will not count as prior

publication.

We advise you to read our policy on multiple, redundant or concurrent publication.

Image manipulation

We

accept that authors sometimes need to adjust images for clarity but any

manipulation of images for the purpose of deception or fraud will be

seen as scientific ethical abuse and will be dealt with accordingly.

Authors must adhere to this journal’s policy for graphical images:

No specific feature within an image may be enhanced, obscured, moved, removed or introduced.

Adjustments

of brightness, contrast, or color balance are acceptable if, and only

as long as, they do not obscure or eliminate any information present in

the original image.

Nonlinear adjustments such as changes to gamma settings must be disclosed in the figure legend.

We

do not permit the use of generative AI or AI-assisted tools to create

or alter images in submitted manuscripts. Please read our policy on the

use of generative AI and AI-assisted tools in figures, images and

artwork, which can be found in Elsevier’s GenAI Policies for Journals.

To

verify compliance with the above, this journal may send your images to a

third-party service who screen for image irregularities. Our editors

may ask you to provide original data or images if any questions arise as

a result of the screening. The final decision as to whether images are

acceptable will be taken by our editors.

Authors

are encouraged to carefully check all images before submission and to

connect all the data in any figures to the original, unprocessed data.

Studies in humans

Authors must follow ethical guidelines for studies carried out in humans.

Work

which involves the use of human subjects should be carried out in

accordance with the World Medical Association Declaration of Helsinki:

Ethical principles for medical research involving human subjects.

Manuscripts

should follow the International Committee of Medical Journal Editors

(ICMJE) recommendations for the conduct, reporting, editing and

publication of scholarly work in medical journals and aim to be

representative of human populations in terms of sex, age and ethnicity.

Sex and gender terms should be used correctly, as outlined by WHO (World

Health Organization).

Manuscripts

must include a statement that all procedures were performed in

compliance with relevant laws and institutional guidelines and have been

approved by the appropriate institutional committee(s). The statement

should contain the date and reference number of the ethical approval(s)

obtained.

Manuscripts must also include a statement that informed consent was obtained for experimentation with human subjects.

Studies in animals

Authors must follow ethical guidelines for studies carried out in animals.

All animal experiments should comply with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.

Studies

should be carried out in accordance with Guidance on the operation of

the Animals (Scientific Procedures) Act 1986 and associated guidelines,

EU Directive 2010/63 for the protection of animals used for scientific

purposes or the NIH (National Research Council) Guide for the Care and

Use of Laboratory Animals (PDF).

The

sex of animals, and where appropriate, the influence (or association)

of sex on the results of the study must be indicated and a statement

included in your manuscript that such guidelines as listed above have

been followed.

Informed consent and patient details

Authors

must document in the manuscript that ethics committee approval and

informed consent have been obtained for studies involving patients or

volunteers (including organ/tissue donors). Key guidelines:

Appropriate

consents, permissions and releases must be obtained if case details,

personal information and images of patients or any other individuals are

included in a publication, even if anonymized.

Patient

and research subjects’ names, initials, hospital or social security

numbers, dates of birth or any other personal or identifying information

should never be used, even where consent has been provided.

Written

consents must be retained. They should not be provided to this journal

unless this is specifically requested in exceptional circumstances, for

example, when a legal issue arises. Only then should you provide copies

of the consents, or evidence that all relevant consents were obtained.

Personal

details of any patient must only be included in your article or in any

supplementary materials (including all images and videos) in cases where

written permission has been given by the patient (or, where applicable,

the next of kin).

We advise you to review Elsevier’s policy on patient consent prior to preparing your manuscript.

Clinical Trials

This journal follows the International Committee of Medical Journal Editors (ICMJE) clinical trials registration guidelines.

Registration

Clinical trials must be registered in a public trials registry.  Purely

observational studies, in which the assignment of the medical

intervention is not at the discretion of the investigator, do not

require registration.

Some important points:

Trials must be registered at or before the onset of patient enrolment.

The clinical trial registration number must be included in the manuscript, preferably at the end of the article abstract.

A

clinical trial is defined as any research study that prospectively

assigns human participants, or groups of humans, to one or more

health-related interventions to evaluate the effects of health outcomes.

Health-related

interventions include any intervention used to modify a biomedical or

health-related outcome such as drugs, surgical procedures, devices,

behavioral treatments, dietary interventions, and process-of-care

changes.

Health

outcomes include any biomedical or health-related measures obtained in

patients or participants, including pharmacokinetic measures and adverse

events.

......

更多详见：

https://www.sciencedirect.com/journal/dental-research/publish/guide-for-authors